Delivery Order SPE2DB22D2007-SPE2DB25FJ4TS
Award Date 9/9/25
Potential Completion Date 9/10/25
Potential Value $36K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $20,455.11 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Activase 50 mg vials, with an ultimate completion date of August 15, 2025. This is a firm fixed-price, non-set-aside contract issued to the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $22,365.75 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. This firm fixed price contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procurement with no set-aside designation. Performance will take place at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,875.45 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. This firm fixed-price contract, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive, non-set-aside award. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $5,935.94 delivery order to AmerisourceBergen Drug Corp for 50 mg vials of Activase, a thrombolytic medication used in acute medical situations. The contract was competitively awarded without set-aside restrictions and carries a firm fixed price structure with an ultimate completion date of September 11, 2025. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $11,730.80 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. The contract, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a firm fixed-price procurement with no set-aside designation. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $36,187.73 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Activase, a thrombolytic medication used in acute medical treatment. This competitively awarded, firm fixed-price contract was issued on September 9, 2025, with an ultimate completion date of September 10, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials valued at $3,351.48. This contract was executed on August 21, 2025, with an ultimate completion date of August 22, 2025, and utilizes firm fixed-price pricing with no set-aside designation. The award was made competitively to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company is headquartered. This...
- The Defense Logistics Agency awarded a $13,058.92 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Activase, a tissue plasminogen activator used for thrombolytic therapy in acute medical emergencies. Issued on September 8, 2025, with completion expected by September 9, 2025, this firm fixed-price contract represents a non-competitive delivery order under the company's existing indefinite delivery contract vehicle. The order will be fulfilled at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $21,231.29 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 14, 2025. AmerisourceBergen Drug Corp will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 50 mg vials of Activase on August 20, 2025, with a contract ceiling value of $3,662.41. This firm fixed-price delivery order, which carries an ultimate completion date of August 21, 2025, represents a competitively awarded non-set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is executed under AmerisourceBergen Drug Corp's larger...